Institutional Ownership
Acurx Pharmaceuticals Inc
CUSIP 00510M203COM NEWACXPQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
20
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Aug 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Aug 14, 2025 | Armistice Capital, LLC | 13G/A | 10.0% | 1.29M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Jane Street Group, LLC | 54.6K | $202.7K |
| 2 | Geode Capital Management, LLC | 24.8K | $92.1K |
| 3 | Prospect Financial Services LLC | 13.8K | $51.1K |
| 4 | Morgan Stanley | 6.5K | $24.1K |
| 5 | Ubs Group AG | 6.3K | $23.4K |
| 6 | Wells Fargo & Company/Mn | 2.3K | $8.5K |
| 7 | Westside Investment Management, Inc. | 1.6K | $6.1K |
| 8 | Nbc Securities, Inc. | 1.5K | $5.6K |
| 9 | Western Wealth Management, LLC | 1.3K | $4.9K |
| 10 | Tower Research Capital LLC (Trc) | 1.0K | $3.8K |